# UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes

> **NCT06407297** · NA · RECRUITING · sponsor: **Shanghai Changzheng Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Newly Diagnosed Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** UCMSCs
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06407297
- **Lead sponsor:** Shanghai Changzheng Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-23
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-05-01
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06407297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06407297, "UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 Diabetes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06407297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*